We found that frailer people experienced larger benefits from SGLT2 inhibitors or GLP-1 receptor agonist treatment than those without frailty, as explicitly shown by the number needed to treat for the primary effectiveness outcome, the researchers wrote
(PubMed) Cederholm T, Palmblad J
Retatrutides Impact In clinical trials, retatrutide produced larger LDL reductions than semaglutide or tirzepatide, even when adjusting for weight loss
The potential of these drugs to lower risks related to obesity and associated conditions is noteworthy
Complementary strategies include managing inflammation through medication or heat and cold therapy, maintaining gentle and consistent daily movement, and ensuring a nutrient-rich diet that supports tissue repair
In a recent study, researchers looked at the effect that the nutrient L-Carnitine had on the heart